These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 21184855)

  • 21. Recombinant BCG-Rv1767 amount determines, in vivo, antigen-specific T cells location, frequency, and protective outcome.
    Speranza V; Colone A; Cicconi R; Palmieri G; Giovannini D; Grassi M; Mattei M; Sali M; Delogu G; Andreola F; Colizzi V; Mariani F
    Microb Pathog; 2010 May; 48(5):150-9. PubMed ID: 20219669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Supplementation with RD antigens enhances the protective efficacy of BCG in tuberculous mice.
    Kalra M; Grover A; Mehta N; Singh J; Kaur J; Sable SB; Behera D; Sharma P; Verma I; Khuller GK
    Clin Immunol; 2007 Nov; 125(2):173-83. PubMed ID: 17766185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mycobacterium bovis BCG vaccination modulates TNF-alpha production after pulmonary challenge with virulent Mycobacterium tuberculosis in guinea pigs.
    Yamamoto T; Lasco TM; Uchida K; Goto Y; Jeevan A; McFarland C; Ly L; Yamamoto S; McMurray DN
    Tuberculosis (Edinb); 2007 Mar; 87(2):155-65. PubMed ID: 17289434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fusion protein Ag85B-MPT64(190-198)-Mtb8.4 has higher immunogenicity than Ag85B with capacity to boost BCG-primed immunity against Mycobacterium tuberculosis in mice.
    Luo Y; Wang B; Hu L; Yu H; Da Z; Jiang W; Song N; Qie Y; Wang H; Tang Z; Xian Q; Zhang Y; Zhu B
    Vaccine; 2009 Oct; 27(44):6179-85. PubMed ID: 19712772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Environmental strains of Mycobacterium avium interfere with immune responses associated with Mycobacterium bovis BCG vaccination.
    Young SL; Slobbe L; Wilson R; Buddle BM; de Lisle GW; Buchan GS
    Infect Immun; 2007 Jun; 75(6):2833-40. PubMed ID: 17371857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunogenicity and protection induced by Mycobacterium tuberculosis mce-2 and mce-3 mutants in a Balb/c mouse model of progressive pulmonary tuberculosis.
    Aguilar LD; Infante E; Bianco MV; Cataldi A; Bigi F; Pando RH
    Vaccine; 2006 Mar; 24(13):2333-42. PubMed ID: 16388878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Region of difference 2 contributes to virulence of Mycobacterium tuberculosis.
    Kozak RA; Alexander DC; Liao R; Sherman DR; Behr MA
    Infect Immun; 2011 Jan; 79(1):59-66. PubMed ID: 20974821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunization of mice after airborne infection with various strains of BCG.
    Lefford MJ
    Am Rev Respir Dis; 1978 Jan; 117(1):103-9. PubMed ID: 339795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protection of mice against Mycobacterium tuberculosis infection by immunization with aqueous fraction of Triton X-100-soluble cell wall proteins.
    Jeon BY; Kim HJ; Kim SC; Jo EK; Park JK; Paik TH; Kim SJ; Cho SN
    Scand J Immunol; 2008 Jan; 67(1):18-23. PubMed ID: 18021187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mucosal immunization with recombinant heparin-binding haemagglutinin adhesin suppresses extrapulmonary dissemination of Mycobacterium bovis bacillus Calmette-Guérin (BCG) in infected mice.
    Kohama H; Umemura M; Okamoto Y; Yahagi A; Goga H; Harakuni T; Matsuzaki G; Arakawa T
    Vaccine; 2008 Feb; 26(7):924-32. PubMed ID: 18192091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decrease in the effectiveness of Bacille Calmette-Guérin vaccine against pulmonary tuberculosis: a consequence of increased immune suppression by microbial antioxidants, not overattenuation.
    Kernodle DS
    Clin Infect Dis; 2010 Jul; 51(2):177-84. PubMed ID: 20524854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Difference in TB10.4 T-cell epitope recognition following immunization with recombinant TB10.4, BCG or infection with Mycobacterium tuberculosis.
    Billeskov R; Grandal MV; Poulsen C; Christensen JP; Winther N; Vingsbo-Lundberg C; Hoang TT; van Deurs B; Song YH; Aagaard C; Andersen P; Dietrich J
    Eur J Immunol; 2010 May; 40(5):1342-54. PubMed ID: 20186878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective efficacy of intranasal vaccination with Mycobacterium bovis BCG against airway Mycobacterium tuberculosis challenge in mice.
    Giri PK; Verma I; Khuller GK
    J Infect; 2006 Nov; 53(5):350-6. PubMed ID: 16442629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis.
    Pym AS; Brodin P; Majlessi L; Brosch R; Demangel C; Williams A; Griffiths KE; Marchal G; Leclerc C; Cole ST
    Nat Med; 2003 May; 9(5):533-9. PubMed ID: 12692540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The BCGΔBCG1419c strain, which produces more pellicle in vitro, improves control of chronic tuberculosis in vivo.
    Pedroza-Roldán C; Guapillo C; Barrios-Payán J; Mata-Espinosa D; Aceves-Sánchez Mde J; Marquina-Castillo B; Hernández-Pando R; Flores-Valdez MA
    Vaccine; 2016 Sep; 34(40):4763-70. PubMed ID: 27546876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deletion of zmp1 improves Mycobacterium bovis BCG-mediated protection in a guinea pig model of tuberculosis.
    Sander P; Clark S; Petrera A; Vilaplana C; Meuli M; Selchow P; Zelmer A; Mohanan D; Andreu N; Rayner E; Dal Molin M; Bancroft GJ; Johansen P; Cardona PJ; Williams A; Böttger EC
    Vaccine; 2015 Mar; 33(11):1353-9. PubMed ID: 25657094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular analysis of the bacille Calmette-Guérin vaccine strain currently being used in Iran.
    Fallah F; Karimi A; Abdolghafoorian H; Mohammadzadeh A; Zahraei SM; Goudarzi H; Fallah M
    Int J Tuberc Lung Dis; 2016 Feb; 20(2):223-7. PubMed ID: 26792475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tuberculosis vaccine strain Mycobacterium bovis BCG Russia is a natural recA mutant.
    Keller PM; Böttger EC; Sander P
    BMC Microbiol; 2008 Jul; 8():120. PubMed ID: 18637199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolution and Strain Variation in BCG.
    Abdallah AM; Behr MA
    Adv Exp Med Biol; 2017; 1019():155-169. PubMed ID: 29116634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the immunogenic capability of the BCG strains BCGΔBCG1419c and BCGΔBCG1416c in a three-dimensional human lung tissue model.
    Parasa VR; Rose J; Castillo-Diaz LA; Aceves-Sánchez MJ; Vega-Domínguez PJ; Lerm M; Flores-Valdez MA
    Vaccine; 2018 Mar; 36(14):1811-1815. PubMed ID: 29475763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.